Trastuzumab deruxtecan treatment for HER2-low metastatic scrotal extramammary Paget’s disease with bone marrow involvement: a case report - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Treatment with Trastuzumab Deruxtecan for Metastatic HER2-Low Scrotal Extramammary Paget’s Disease Involving Bone Marrow: A Case Study

  • By

  • Yi Bao

  • Lei Zhang

  • Fenfen Jiang

  • Juanfen Mo

  • September 1, 2026

Share

Original Source(s)

Related Content